Cara Cassino
Plus aucun poste en cours
Fortune : - $ au 30/04/2024
Historique de carrière de Cara Cassino
Anciens postes connus de Cara Cassino
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CONTRAFECT CORPORATION | Directeur Technique/Scientifique/R&D | 25/09/2015 | 14/08/2022 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/12/2014 | 01/09/2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2008 | 01/01/2013 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Directeur Technique/Scientifique/R&D | 01/01/2001 | 01/01/2007 |
| New York University School of Medicine | Corporate Officer/Principal | - | - |
Formation de Cara Cassino
| NYU College of Dentistry | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bourse
- Insiders
- Cara Cassino
- Expérience